You have 9 free searches left this month | for more free features.

nnc0114-0006

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 1 Trial in Worldwide (NNC0114-0006, liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • NNC0114-0006
  • +2 more
  • La Jolla, California
  • +107 more
Mar 10, 2021

Inflammation, Rheumatoid Arthritis Trial in Berlin, Moscow, Yaroslavl (NNC0114-0006, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • NNC0114-0006
  • placebo
  • Berlin, Germany
  • +4 more
Feb 6, 2017

Inflammation, Crohn's Disease Trial in Worldwide (NNC0114-0006, )

Completed
  • Inflammation
  • Crohn's Disease
  • NNC0114-0006
  • placebo
  • Tucson, Arizona
  • +27 more
Mar 30, 2017

Inflammation, Rheumatoid Arthritis Trial in Worldwide (NNC0114-0006, )

Completed
  • Inflammation
  • Rheumatoid Arthritis
  • NNC0114-0006
  • placebo
  • Plovdiv, Bulgaria
  • +32 more
Feb 6, 2017

Inflammation, Systemic Lupus Erythematosus Trial in Worldwide (NNC0114-0006, )

Terminated
  • Inflammation
  • Systemic Lupus Erythematosus
  • NNC0114-0006
  • placebo
  • La Jolla, California
  • +4 more
Apr 7, 2014